3 Big Pharmas That Could be Winners for Investors in the Long Run Post author:Sam Post published:November 29, 2017 Post category:BioPharma Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace You Might Also Like Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017 Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017 FDA Green Lights Gilead's Vosevi, With a Black Box Warning Attached July 18, 2017
Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017
Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017
